Aktuellt
SENASTE
Redeye expects the first sales of Sedaconda in the UK by year-end, following today’s full UK approval of Sedana Medical’s inhalation sedation solution. We make no estimate changes on the news and reiterate our fair value range. However, we are encouraged to finally see the UK giving full approval for the treatment and believe that the NICE clinical guidelines position the company well on this particular market. Next up for the UK market is gaining reimbursement, which we expect could take some weeks.
LÄS MER
